1. J.W. Hadden and A. Giner-Sorolla, Isoprinosine and NPT 15392: Modulators of lymphocyte and macrophage development and function, Augmenting Agents in Cancer Therapy, p. 497 (1981).
2. J.W. Hadden, The action of immunopotentiators in vitro on lymphocytes and macrophage proliferation, in: “The Pharmacology of Immunoregulation,” G. Werner, and F. Floch, eds., Academic Press, London, p. 369 (1978).
3. J.W. Hadden, R.G. Coffey, and E.M. Hadden, Isoprinosine augmentation of phytohemagglutinin-induced lymphocyte proliferation, Infect. Immun. 13: 382 (1976).
4. A. Morin, J.L. Touraine, G. Renoux, and J.W. Hadden, Isoprinosine as immunomodulating agent, Symposium of New Trends in Human Immunology and Cancer Immunotherapy, Montpellier, France, Jan. 17–19 (1980).
5. J. Wybran, Immunomodulatory properties of isoprinosine in man: In vitro and in vivo data, Int. Symposium on New Trends in Human Immunology and Cancer Immunotherapy, p. 1014 (1980).